FOLD

Amicus Therapeutics, Inc. Press Releases

$8.48
*  
unch
unch
Get FOLD Alerts
*Delayed - data as of Mar. 4, 2015 13:33 ET  -  Find a broker to begin trading FOLD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FOLD Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Amicus Therapeutics Announces Full-Year 2014 Financial Results and Corporate Updates
3/3/2015 4:01:00 PM - GlobeNewswire


Amicus Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference
2/26/2015 8:47:00 AM - GlobeNewswire


Amicus Therapeutics to Announce Full-Year 2014 Financial Results on March 3, 2015
2/25/2015 9:12:00 AM - GlobeNewswire


Amicus Therapeutics Announces Additional Positive Phase 3 Fabry Data on Patient Reported Outcomes at WORLDSymposium(TM) 2015
2/10/2015 7:01:00 AM - GlobeNewswire


Amicus Therapeutics Presents Preclinical Data on Next-Generation Pompe ERT at WORLDSymposium(TM) 2015
2/10/2015 7:00:00 AM - GlobeNewswire


Amicus Therapeutics to Present at Leerink Global Healthcare Conference
2/4/2015 4:00:00 PM - GlobeNewswire


National Tay Sachs and Allied Diseases Recruits Industry Leaders for Advisory Council
1/30/2015 10:27:00 AM - eTeligis


Amicus Therapeutics Announces Presentations and Posters at Lysosomal Disease Network WORLD Symposium
1/26/2015 7:30:00 AM - GlobeNewswire


Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance
1/12/2015 7:30:00 AM - GlobeNewswire


Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study
1/8/2015 7:30:00 AM - GlobeNewswire


Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference
12/22/2014 7:30:00 AM - GlobeNewswire


Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI)
12/22/2014 7:30:00 AM - GlobeNewswire


Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease
12/11/2014 7:30:00 AM - GlobeNewswire